None of the cases with detectable antibodies had typical epidemiological associations with cancer or high-risk PNS phenotypes (4/8 (50%) anti-Yo in male patients without cerebellar syndrome). This evidence concerns the gene CDR2 and paraneoplastic neurologic syndrome.